Computer-assisted therapy for medication-resistant auditory hallucinations: proof-of-concept study

• Published in: British journal of psychiatry 2013-06, Vol.202 (6), p.428-433
• Main Authors: Leff, Julian, Williams, Geoffrey, Huckvale, Mark A., Arbuthnot, Maurice, Leff, Alex P.
• Format: Article
• Language: English
• Subjects: Antipsychotic drugs; Antipsychotics; Auditory hallucinations; Auditory perception; Cancer therapies; Cross-Over Studies; Declarations; Depression; Female; Group therapy; Hallucinations; Hallucinations - therapy; Hearing; Humans; Male; Mental depression; Mental disorders; Omnipotence; Patients; Psychiatry; Psychosis; Questionnaires; Schizophrenia; Single-Blind Method; Software; Surveys and Questionnaires; Therapists; Therapy; Therapy, Computer-Assisted - methods; Treatment Outcome
• ISSN: 0007-1250; 1472-1465
• DOI: 10.1192/bjp.bp.112.124883

One in four patients with schizophrenia responds poorly to antipsychotic medication, continuing to hear persecutory auditory hallucinations. Patients who are able to sustain a dialogue with their persecutor feel much more in control. To develop a computerised system that enables the patient to create an avatar of their persecutor. To encourage them to engage in a dialogue with the avatar, which the therapist is able to control so that the avatar progressively yields control to the patient. Avatar therapy was evaluated by a randomised, single blind, partial crossover trial comparing the novel therapy with treatment as usual (TAU). We used three main outcome measures: (a) the Psychotic Symptom Rating Scale (PSYRATS), hallucinations section; (b) the Omnipotence and Malevolence subscales of the Revised Beliefs About Voices Questionnaire (BAVQ-R); and (c) the Calgary Depression Scale (CDS). The control group showed no change over time in their scores on the three assessments, whereas the novel therapy group showed mean reductions in the total PSYRATS score (auditory hallucinations) of 8.75 (P = 0.003) and in the BAVQ-R combined score of omnipotence and malevolence of the voices of 5.88 (P = 0.004). There was no significant reduction in the CDS total score for depression. For the crossover control group, comparison of the period of TAU with the period of avatar therapy confirmed the findings of the previous analysis. The effect size of the therapy was 0.8. Avatar therapy represents a promising treatment for medication-resistant auditory hallucinations. Replication with a larger sample is required before roll-out to clinical settings.